Skip to main content

MARSHALL WACE, LLP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1318757 LONDON, X0

Position in MDGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$54,693,189
+$43,228,150 QoQ
Shares Held
101,859
+365.1% QoQ
Ownership
0.441%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#43
of 411 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. MDGL ranks #11 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MDGL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $54,693,189 101,859
2026-03-31 $11,465,039 21,902
2025-12-31 $23,047,851 39,578
2025-09-30 $321,062 700
2025-06-30 $16,681,212 55,119
2025-03-31 $927,444 2,800
2024-12-31 $5,398,123 17,494
2024-09-30 $17,062,700 80,401
2024-06-30 $476,272 1,700
2023-12-31 $7,651,967 33,071
2023-09-30 $57,743,922 395,398
2023-06-30 $106,408,764 460,644
2023-03-31 $131,247,745 541,764
2021-12-31 $51,521 608
2021-06-30 $9,563,713 98,180